MARDJAN FOROUTAN: Open Payments
NPI 1619900024 · SYCAMORE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 16 payments from 8 companies in 2025. Trend: 2023 $691 · 2024 $642 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $289 |
| Axsome Therapeutics, Inc. | 3 | $180 |
| Alkermes, Inc. | 2 | $124 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| ABBVIE INC. | 1 | $26 |
| Lundbeck LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: CAPLYTA, Auvelity, ARISTADA, INGREZZA, REXULTI, VRAYLAR, UZEDY, AUSTEDO XR.
Industry payments across IL — which companies pay providers there.
